Summit Therapeutics Inc.

19.09
-1.60 (-7.73%)
At close: Mar 03, 2025, 3:59 PM
18.89
-1.07%
Pre-market: Mar 04, 2025, 08:03 AM EST

Summit Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Cash & Equivalents 104.86M 71.42M 348.61M 71.79M 66.42M 49.96M 35.23M 28.45M 35.08M 23.22M 16.97M 3.35M 5.34M 3.26M 5.14M 9.72M 3.92M 20.06M 35.87M 22.55M 26.66M 145.96K
Short-Term Investments 307.49M 114.82M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 20.7M n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 1.47 0.00 -0.00 0.89 -0.00 1.97 -0.00 n/a
Other Long-Term Assets 2.55M 5.28M 577K 170K 21.26M 3.27M 1.00 -0.00 n/a n/a 1.00 n/a n/a -3.26M -5.14M -9.72M -3.92M -20.06M -35.87M -1.86M -26.66M n/a
Receivables n/a 848K 349K 1.46M 10.19M 5.29M n/a 11.09M n/a 2.28M n/a n/a n/a n/a n/a n/a 1.05M 1.46M 1.27M 0.00 n/a n/a
Inventory n/a n/a 301.5M 7.16M -11.71M 1.56 n/a n/a 110.56K 563.1K 4.16M 1.00 n/a n/a n/a n/a 563.98K 670.13K 369.35K 48.2K n/a n/a
Other Current Assets 11.4M 2.62M 301.99M 8.36M 11.07M 13.47M 25.99M 22.28M 5.45M 6.46M 5.26M 1.76M 1.27M 890.36K 761.18K 881.87K 2.27M 3.11M 2.19M 965.74K 175.1K n/a
Total Current Assets 423.75M 189.71M 656.71M 97.31M 66.42M 62.11M 61.29M 50.8M 41.67M 29.7M 22.89M 5.11M 6.61M 4.15M 5.9M 10.6M 7.79M 25.3M 38.43M 23.57M 26.84M 145.96K
Property-Plant & Equipment 7.4M 6.06M 5.08M 3.48M 1.28M 1.2M 807.92K 1.15M 144.99K 118.21K 82.87K 70.93K 36.33K 233.97K 411.45K 535.2K 5.35M 8.49M 5.15M 2.25M 1.88K n/a
Goodwill & Intangibles 1.86M 1.89M 1.8M 12.41M 13.54M 8.87M 16.29M 24.44M 5.17M 5.89M 6.25M 5.76M 270.1K 1.73M 1.74M 7.25M 6.95M 35.59M 2.86M 49.98K 37.66K n/a
Total Long-Term Assets 11.81M 13.24M 7.46M 16.06M 36.08M 13.34M 17.09M 25.58M 5.31M 6.01M 6.33M 5.83M 306.42K 1.97M 2.15M 7.78M 12.3M 44.08M 8.01M 2.3M 39.54K n/a
Total Assets 435.56M 202.95M 664.17M 113.37M 102.5M 75.46M 78.39M 76.38M 46.98M 35.71M 29.22M 10.94M 6.91M 6.12M 8.06M 18.38M 20.09M 69.38M 46.44M 25.87M 26.88M 145.96K
Account Payables 4.64M 2.67M 355K 4.37M 6.14M 2.63M 5.8M 12.49M 1.13M 1.02M 5.38M 575.68K 401.19K 584.15K 525.39K 238.04K 972.87K 3.61M 2.26M 871.13K 33.89K n/a
Deferred Revenue n/a n/a n/a 7.94M 8.37M 1.17M n/a -18.03M 8.64M n/a n/a n/a 924.01K n/a n/a n/a -1.52M -2.81M -453.11K -988.95K n/a n/a
Short-Term Debt 3.77M 2.81M 21.46M 1.09M 390K 988.19K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 194.57K 373.84K 129.46K 117.82K n/a n/a
Other Current Liabilities 33.33M 14.93M 16.97M 12.5M 4.99M 7.53M 10.83M 19.81M 9.65M 3.43M 203.41K 2.41M 1.01M 1.43M 1.39M 1.53M 1.52M 2.81M 453.11K 269.55K 316.32K 3.65K
Total Current Liabilities 41.73M 20.41M 38.78M 25.62M 19.89M 9.9M 16.88M 26.81M 13.62M 4.57M 5.67M 3.08M 2.41M 2.02M 1.91M 1.76M 2.69M 6.6M 2.84M 1.26M 350.21K 3.65K
Long-Term Debt 3.45M 103.29M 497.3M 1.25M 75K 318.56K n/a -16.25M n/a n/a n/a n/a n/a n/a n/a n/a 1.7M 2.43M 1.17M 1.23M n/a n/a
Other Long-Term Liabilities 1.63M 1.56M 1.43M 3.22M 2.51M 2.2M 3.28M 5.73M -39.87K 7.27M n/a n/a n/a 321.91K 324.41K 1.89M 1.9M 2.35M 2.31M n/a n/a n/a
Total Long-Term Liabilities 5.08M 104.85M 498.73M 4.47M 3.15M 4.44M 5.71M 35.59M 37.73M 1.05M 1M n/a n/a 321.91K 324.41K 3.39M 5.08M 8.71M 3.49M 1.23M n/a n/a
Total Liabilities 46.81M 125.26M 537.51M 30.09M 23.05M 14.34M 22.59M 62.4M 51.35M 5.62M 6.67M 3.08M 2.41M 2.34M 2.24M 5.15M 7.77M 15.3M 6.33M 2.49M 350.21K 3.65K
Total Debt 7.22M 106.1M 518.76M 2.78M 465K 699.64K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.9M 2.8M 1.3M 1.35M n/a n/a
Common Stock 7.38M 7.02M 2.11M 980K 826K 3.47M 2.1M 1.04M 772.47K 873.03K 619.25K 16.62M 13.88M 11.18M 10.97M 11.04M 8.07M 12.75M 7.3M 5.59M 5.9M 1.82K
Retained Earnings -1.21B -993.26M -378.33M -299.55M -214.74M -97.61M -99.8M -114.51M -92.21M -67.43M -45.59M -74.53M -61.74M -54.75M -50.91M -43.9M -52.84M -28.35M -8.11M -1.99M -86.61K -40.14K
Comprehensive Income -2.29M -2.45M -1.89M -2.2M -3.79M 22.03M n/a n/a 25.74M 27.29M -3.21M -3.21M -3.07M -1.74M -1.6M -5.23M -3.17M -2.45M -917.99K -228.49K -1.88K n/a
Shareholders Equity 388.75M 77.69M 126.65M 83.28M 79.45M 61.12M 55.8M 13.98M -4.37M 30.1M 22.55M 7.85M 4.5M 3.78M 5.82M 13.22M 12.33M 54.08M 40.11M 23.38M 26.53M 142.31K
Total Investments 307.49M 114.82M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 1.47 0.00 -0.00 0.89 -0.00 20.7M -0.00 n/a